Double-blind, randomized, placebo-controlled study to assess efficacy and safety of clazosentan to reduce vasospasm-related and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping (Conscious-2), Actelion

University Hospitals Case Medical Center. 2009 – 2010